These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 17904294)

  • 21. Beyond detectable minimal residual disease in chronic lymphocytic leukemia.
    Hillmen P
    Semin Oncol; 2006 Apr; 33(2 Suppl 5):S23-8. PubMed ID: 16720200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia.
    Del Poeta G; Del Principe MI; Buccisano F; Maurillo L; Capelli G; Luciano F; Perrotti AP; Degan M; Venditti A; de Fabritiis P; Gattei V; Amadori S
    Cancer; 2008 Jan; 112(1):119-28. PubMed ID: 17999417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in chronic lymphocytic leukemia.
    Abbott BL
    Cancer Invest; 2006; 24(3):302-9. PubMed ID: 16809159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical and epidemiological burden of chronic lymphocytic leukaemia.
    Redaelli A; Laskin BL; Stephens JM; Botteman MF; Pashos CL
    Eur J Cancer Care (Engl); 2004 Jul; 13(3):279-87. PubMed ID: 15196232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of stem-cell transplantation in chronic lymphocytic leukemia risk-adapted therapy.
    Giné E; Moreno C; Esteve J; Montserrat E
    Best Pract Res Clin Haematol; 2007 Sep; 20(3):529-43. PubMed ID: 17707838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of relapsed chronic lymphocytic leukemia: old and new therapies.
    Byrd JC; Lin TS; Grever MR
    Semin Oncol; 2006 Apr; 33(2):210-9. PubMed ID: 16616068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia.
    Robak T; Smolewski P; Cebula B; Grzybowska-Izydorczyk O; Błoński JZ
    Eur J Haematol; 2007 Aug; 79(2):107-13. PubMed ID: 17635235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the optimal initial treatment for chronic lymphocytic leukemia?
    Lin TS
    Oncology (Williston Park); 2007 Dec; 21(14):1641-9; discussion 1649-54, 1659, 1662. PubMed ID: 18247015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
    Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC
    Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab, fludarabine, cyclophosphamide, and mitoxantrone: a new, highly active chemoimmunotherapy regimen for chronic lymphocytic leukemia.
    Bosch F; Abrisqueta P; Villamor N; Terol MJ; González-Barca E; Ferra C; González Diaz M; Abella E; Delgado J; Carbonell F; García Marco JA; Escoda L; Ferrer S; Monzó E; González Y; Estany C; Jarque I; Salamero O; Muntañola A; Montserrat E
    J Clin Oncol; 2009 Sep; 27(27):4578-84. PubMed ID: 19704063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
    Bosch F; Ferrer A; Villamor N; González M; Briones J; González-Barca E; Abella E; Gardella S; Escoda L; Pérez-Ceballos E; Asensi A; Sayas MJ; Font L; Altés A; Muntañola A; Bertazzoni P; Rozman M; Aymerich M; Giné E; Montserrat E
    Clin Cancer Res; 2008 Jan; 14(1):155-61. PubMed ID: 18172266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia.
    Banerji V; Johnston JB; Seftel MD
    Transfus Apher Sci; 2007 Aug; 37(1):57-62. PubMed ID: 17919979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic lymphatic leukemia].
    Lechner K; Bilbeisi S; Wittmann E; Wilfing A
    Wien Klin Wochenschr; 1994; 106(10):291-9. PubMed ID: 8053196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous stem cell transplantation for chronic lymphocytic leukemia.
    Dreger P; Brand R; Michallet M
    Semin Hematol; 2007 Oct; 44(4):246-51. PubMed ID: 17961723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of nucleoside analogues in the treatment of chronic lymphocytic leukemia-lessons learned from prospective randomized trials.
    Robak T
    Leuk Lymphoma; 2002 Mar; 43(3):537-48. PubMed ID: 12002757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial therapy for patients with chronic lymphocytic leukemia.
    Wierda WG; O'Brien SM
    Semin Oncol; 2006 Apr; 33(2):202-9. PubMed ID: 16616067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status and future directions of clinical trials in chronic lymphocytic leukemia.
    Nerenstone SR; Archer JI; Cheson BD
    Oncology (Williston Park); 1987 Oct; 1(8):31-40, 44. PubMed ID: 3079490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances in the treatment of chronic lymphocytic leukemia (CLL)].
    Lechner K; Jäger U; Geissler K; Greinix H; Kalhs P
    Wien Klin Wochenschr; 1998 Oct; 110(20):701-8. PubMed ID: 9857427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies.
    Robak T
    Drugs Aging; 2005; 22(12):983-1012. PubMed ID: 16363884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.